Latest filing published 18 May 2026 for 레이.
All filings by 엘앤씨바이오 on record concern 레이. The record holds 2 filings, for trades running from 27 August 2024 to 27 March 2026.
In open-market terms, that means 1 purchase on one side and 1 sale on the other. The totals exclude 2 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at no purchases and 1 sale.
On 18 May 2026 came the latest disclosure, an open-market sale in 레이. The clock since the last published purchase (30 April 2025) now reads 543 days. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.